| 1 | Digeorge syndrome | Enrichment | ARVCF, COMT, GP1BB, HIRA, TBX1, UFD1 | 9.19 |
| 2 | Lung cancer susceptibility 3 | Enrichment | ACTA2, EGFR, FGF10, PRKN, TP53 | 6.84 |
| 3 | Bernard-soulier syndrome | Enrichment | GP1BA, GP1BB, GP9 | 5.06 |
| 4 | Gliosarcoma | Enrichment | EGFR, FGFR1, LZTR1, TP53 | 4.86 |
| 5 | Giant cell glioblastoma | Enrichment | EGFR, FGFR1, LZTR1, TP53 | 4.75 |
| 6 | Epilepsy, familial focal, with variable foci 1 | Enrichment | DEPDC5, NPRL2, NPRL3 | 4.52 |
| 7 | Noonan syndrome 1 | Enrichment | LZTR1, PPP1CB, RAF1, SHOC2 | 4.20 |
| 8 | Axenfeld-rieger anomaly with partially absent eye muscles, distinctive face, hydrocephaly, and skeletal abnormalities | Enrichment | FOXC1, PITX2 | 4.03 |
| 9 | Pfeiffer syndrome | Enrichment | FGFR1, FGFR2 | 4.03 |
| 10 | Jackson-weiss syndrome | Enrichment | FGFR1, FGFR2 | 4.03 |
| 11 | Noonan syndrome-like disorder with loose anagen hair | Enrichment | PPP1CB, SHOC2 | 4.03 |
| 12 | Axenfeld-rieger syndrome | Enrichment | FOXC1, PITX2 | 4.03 |
| 13 | Rasopathy | Enrichment | LZTR1, PPP1CB, RAF1, SHOC2 | 3.98 |
| 14 | Lacrimoauriculodentodigital syndrome 1 | Enrichment | FGF10, FGFR2 | 3.56 |
| 15 | Heparin cofactor ii deficiency | Enrichment | PI4KA, SERPIND1 | 3.56 |
| 16 | Epilepsy with auditory features | Enrichment | DEPDC5, RELN | 3.56 |
| 17 | Noonan syndrome and noonan-related syndrome | Enrichment | LZTR1, RAF1, SHOC2 | 3.43 |
| 18 | Microform holoprosencephaly | Enrichment | FGF8, FGFR1, SHH | 3.35 |
| 19 | Lobar holoprosencephaly | Enrichment | FGF8, FGFR1, SHH | 3.35 |
| 20 | Semilobar holoprosencephaly | Enrichment | FGF8, FGFR1, SHH | 3.19 |
| 21 | Rhabdomyosarcoma 2 | Enrichment | PAX3, TP53 | 3.04 |
| 22 | Holoprosencephaly | Enrichment | FGF8, FGFR1 | 3.04 |
| 23 | Persistent truncus arteriosus | Enrichment | NKX2-5, TBX1 | 3.04 |
| 24 | Thrombocytopenia | Enrichment | GP1BA, GP1BB, GP9, VWF | 2.93 |
| 25 | Conotruncal heart malformations | Enrichment | NKX2-5, TBX1 | 2.87 |
| 26 | Holoprosencephaly 1 | Enrichment | FGF8, FGFR1 | 2.87 |
| 27 | Fetomaternal alloimmune thrombocytopenia 1 | Enrichment | GP1BA, GP1BB | 2.87 |
| 28 | Familial isolated dilated cardiomyopathy | Enrichment | ACTC1, HAND2, RAF1, TXNRD2 | 2.77 |
| 29 | Squamous cell carcinoma, head and neck | Enrichment | EGFR, TP53 | 2.73 |
| 30 | Pilomyxoid astrocytoma | Enrichment | FGFR1, RAF1 | 2.73 |
| 31 | Glioma susceptibility 1 | Enrichment | LZTR1, TP53 | 2.60 |
| 32 | Schizophrenia | Enrichment | COMT, PRKN, RELN, RTN4R | 2.60 |
| 33 | Lung cancer | Enrichment | ACTA2, EGFR, PRKN | 2.45 |
| 34 | Meier-gorlin syndrome 1 | Enrichment | CDC45, FGFR2 | 2.40 |
| 35 | Peters-plus syndrome | Enrichment | FOXC1, PITX2 | 2.40 |
| 36 | Autosomal dominant macrothrombocytopenia | Enrichment | GP1BA, GP1BB | 2.40 |
| 37 | Left ventricular noncompaction | Enrichment | ACTC1, NKX2-5, RAF1 | 2.34 |
| 38 | Septooptic dysplasia | Enrichment | FGFR1, SHH | 2.24 |
| 39 | Lip and oral cavity carcinoma | Enrichment | EGFR, TP53 | 2.24 |
| 40 | Anterior segment dysgenesis | Enrichment | FOXC1, PITX2 | 2.05 |
| 41 | Septopreoptic holoprosencephaly | Enrichment | FGF8, SHH | 2.05 |
| 42 | Midline interhemispheric variant of holoprosencephaly | Enrichment | FGF8, SHH | 2.05 |
| 43 | Holoprosencephaly 3 | Enrichment | SHH | 2.02 |
| 44 | Bernard-soulier syndrome, type a2, autosomal dominant | Enrichment | GP1BA | 2.02 |
| 45 | Craniofacial-deafness-hand syndrome | Enrichment | PAX3 | 2.02 |
| 46 | Arthritis, sacroiliac | Enrichment | RELN | 2.02 |
| 47 | Beare-stevenson cutis gyrata syndrome | Enrichment | FGFR2 | 2.02 |
| 48 | Osteoglophonic dysplasia | Enrichment | FGFR1 | 2.02 |
| 49 | Atrial septal defect 7 with or without atrioventricular conduction defects | Enrichment | NKX2-5 | 2.02 |
| 50 | Waardenburg syndrome, type 3 | Enrichment | PAX3 | 2.02 |
| 51 | Trigonocephaly 1 | Enrichment | FGFR1 | 2.02 |
| 52 | Velocardiofacial syndrome | Enrichment | TBX1 | 2.02 |
| 53 | Axenfeld-rieger syndrome, type 1 | Enrichment | PITX2 | 2.02 |
| 54 | Hypertelorism and tetralogy of fallot | Enrichment | FOXC1 | 2.02 |
| 55 | Von willebrand disease, type 1 | Enrichment | VWF | 2.02 |
| 56 | Hypothyroidism, congenital, nongoitrous, 5 | Enrichment | NKX2-5 | 2.02 |
| 57 | Digeorge syndrome/velocardiofacial syndrome complex 2 | Enrichment | DGCR2 | 2.02 |
| 58 | Nonarteritic anterior ischemic optic neuropathy | Enrichment | GP1BA | 2.02 |
| 59 | Noonan syndrome 5 | Enrichment | RAF1 | 2.02 |
| 60 | Von willebrand disease, platelet-type | Enrichment | GP1BA | 2.02 |
| 61 | Scaphocephaly, maxillary retrusion, and impaired intellectual development | Enrichment | FGFR2 | 2.02 |
| 62 | Intellectual developmental disorder, autosomal dominant 3 | Enrichment | CDH15 | 2.02 |
| 63 | Apert syndrome | Enrichment | FGFR2 | 2.02 |
| 64 | Microphthalmia/coloboma 5 | Enrichment | SHH | 2.02 |
| 65 | Mucoepithelial dysplasia, hereditary | Enrichment | SREBF1 | 2.02 |
| 66 | Cardiomyopathy, dilated, 1nn | Enrichment | RAF1 | 2.02 |
| 67 | Anterior segment dysgenesis 4 | Enrichment | PITX2 | 2.02 |
| 68 | Von willebrand disease, type 2 | Enrichment | VWF | 2.02 |
| 69 | Pseudohypoaldosteronism, type iie | Enrichment | CUL3 | 2.02 |
| 70 | Ring dermoid of cornea | Enrichment | PITX2 | 2.02 |
| 71 | Leprosy 2 | Enrichment | PRKN | 2.02 |
| 72 | Aplasia of lacrimal and salivary glands | Enrichment | FGF10 | 2.02 |
| 73 | Bent bone dysplasia syndrome 1 | Enrichment | FGFR2 | 2.02 |
| 74 | Combined d-2- and l-2-hydroxyglutaric aciduria | Enrichment | SLC25A1 | 2.02 |
| 75 | Van den ende-gupta syndrome | Enrichment | SCARF2 | 2.02 |
| 76 | Developmental and epileptic encephalopathy 111 | Enrichment | DEPDC5 | 2.02 |
| 77 | Myasthenic syndrome, congenital, 23, presynaptic | Enrichment | SLC25A1 | 2.02 |
| 78 | Bone marrow failure syndrome 5 | Enrichment | TP53 | 2.02 |
| 79 | Von willebrand disease, type 3 | Enrichment | VWF | 2.02 |
| 80 | Papilloma of choroid plexus | Enrichment | TP53 | 2.02 |
| 81 | Basal cell carcinoma 7 | Enrichment | TP53 | 2.02 |
| 82 | Anaplastic thyroid carcinoma | Enrichment | TP53 | 2.02 |
| 83 | Ifap syndrome 2 | Enrichment | SREBF1 | 2.02 |
| 84 | Lacrimoauriculodentodigital syndrome 3 | Enrichment | FGF10 | 2.02 |
| 85 | Immunodeficiency 42 | Enrichment | RORC | 2.02 |
| 86 | Diaphragmatic hernia 4, with cardiovascular defects | Enrichment | ALDH1A2 | 2.02 |
| 87 | Hyperinsulinemic hypoglycemia, familial, 6 | Enrichment | GLUD1 | 2.02 |
| 88 | Noonan syndrome-like disorder with loose anagen hair 1 | Enrichment | SHOC2 | 2.02 |
| 89 | Glucocorticoid deficiency 5 | Enrichment | TXNRD2 | 2.02 |
| 90 | Leopard syndrome 2 | Enrichment | RAF1 | 2.02 |
| 91 | Tango2-related metabolic encephalopathy and arrythmias | Enrichment | TANGO2 | 2.02 |
| 92 | Radiohumeral fusions with other skeletal and craniofacial anomalies | Enrichment | CYP26B1 | 2.02 |
| 93 | Ventricular septal defect 3 | Enrichment | NKX2-5 | 2.02 |
| 94 | Focal facial dermal dysplasia 4 | Enrichment | CYP26C1 | 2.02 |
| 95 | 2-hydroxyglutaric aciduria | Enrichment | SLC25A1 | 2.02 |
| 96 | Immunodeficiency 12 | Enrichment | MALT1 | 2.02 |
| 97 | Synovitis | Enrichment | RELN | 2.02 |
| 98 | Hypogonadotropic hypogonadism 6 with or without anosmia | Enrichment | FGF8 | 2.02 |
| 99 | Ductal carcinoma in situ | Enrichment | TP53 | 2.02 |
| 100 | Hypoplastic left heart syndrome 2 | Enrichment | NKX2-5 | 2.02 |
| 101 | Metabolic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration | Enrichment | TANGO2 | 2.02 |
| 102 | Hartsfield syndrome | Enrichment | FGFR1 | 2.02 |
| 103 | Neurodevelopmental disorder with or without autism or seizures | Enrichment | CUL3 | 2.02 |
| 104 | Spastic paraplegia 75, autosomal recessive | Enrichment | MAG | 2.02 |
| 105 | Takenouchi-kosaki syndrome | Enrichment | CDC42 | 2.02 |
| 106 | Meier-gorlin syndrome 7 | Enrichment | CDC45 | 2.02 |
| 107 | Noonan syndrome-like disorder with loose anagen hair 2 | Enrichment | PPP1CB | 2.02 |
| 108 | Von willebrand's disease | Enrichment | VWF | 2.02 |
| 109 | Choroid disease | Enrichment | OAT | 2.02 |
| 110 | Lethal occipital encephalocele-skeletal dysplasia syndrome | Enrichment | CYP26B1 | 2.02 |
| 111 | Spastic paraplegia 84, autosomal recessive | Enrichment | PI4KA | 2.02 |
| 112 | Trigonitis | Enrichment | RAF1 | 2.02 |
| 113 | Thyroid gland undifferentiated carcinoma | Enrichment | TP53 | 2.02 |
| 114 | Small-cell carcinoma of the ovary of hypercalcemic type | Enrichment | TP53 | 2.02 |
| 115 | Bernard-soulier syndrome type a2 | Enrichment | GP1BA | 2.02 |
| 116 | Congenital insensitivity to pain with severe intellectual disability | Enrichment | CLTCL1 | 2.02 |
| 117 | Diffuse pediatric-type high-grade glioma, h3-wildtype and idh-wildtype | Enrichment | TP53 | 2.02 |
| 118 | Non-acquired combined pituitary hormone deficiency | Enrichment | FOXA2 | 2.02 |
| 119 | Catechol-o-methyltransferase activity, variation in | Enrichment | COMT | 2.02 |
| 120 | Aortic arch interruption | Enrichment | NKX2-5 | 2.02 |
| 121 | Choroid plexus cancer | Enrichment | TP53 | 2.02 |
| 122 | Nocarh syndrome | Enrichment | CDC42 | 2.02 |
| 123 | Atrial heart septal defect 7 | Enrichment | NKX2-5 | 2.02 |
| 124 | Infection-induced acute-onset axonal neuropathy | Enrichment | RCC1 | 2.02 |
| 125 | Pleomorphic xanthoastrocytoma | Enrichment | TP53 | 2.02 |
| 126 | Gastrointestinal defects and immunodeficiency syndrome 2 | Enrichment | PI4KA | 2.02 |
| 127 | Hartsfield-bixler-demyer syndrome | Enrichment | FGFR1 | 2.02 |
| 128 | Non-syndromic unicoronal craniosynostosis | Enrichment | FGFR2 | 2.02 |
| 129 | Interstitial lung disease specific to childhood | Enrichment | FGF10 | 2.02 |
| 130 | Pi4ka-related disorder | Enrichment | PI4KA | 2.02 |
| 131 | Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome | Enrichment | SHH | 2.02 |
| 132 | Alobar holoprosencephaly | Enrichment | FGF8, SHH | 1.94 |
| 133 | Patent foramen ovale | Enrichment | ACTC1, NKX2-5 | 1.89 |
| 134 | Normosmic congenital hypogonadotropic hypogonadism | Enrichment | FGF8, FGFR1 | 1.89 |
| 135 | Cafe-au-lait spots, multiple | Enrichment | LZTR1 | 1.72 |
| 136 | Adrenocortical carcinoma, hereditary | Enrichment | TP53 | 1.72 |
| 137 | Hyperprolinemia, type i | Enrichment | PRODH | 1.72 |
| 138 | Hyperprolinemia, type ii | Enrichment | ALDH4A1 | 1.72 |
| 139 | Schizophrenia 4 | Enrichment | PRODH | 1.72 |
| 140 | Pulmonary hypoplasia, primary | Enrichment | FGF10 | 1.72 |
| 141 | Cervical cancer | Enrichment | TP53 | 1.72 |
| 142 | Axenfeld-rieger syndrome, type 3 | Enrichment | FOXC1 | 1.72 |
| 143 | Parkinson disease 12 | Enrichment | PRKN | 1.72 |
| 144 | Noonan syndrome 2 | Enrichment | LZTR1 | 1.72 |
| 145 | Aortic aneurysm, familial thoracic 2 | Enrichment | ACTA2 | 1.72 |
| 146 | Nephronophthisis-like nephropathy 1 | Enrichment | RANGAP1 | 1.72 |
| 147 | Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis | Enrichment | CLDN1 | 1.72 |
| 148 | Cardiomyopathy, dilated, 1r | Enrichment | ACTC1 | 1.72 |
| 149 | Atrial fibrillation, familial, 1 | Enrichment | PITX2 | 1.72 |
| 150 | Chromosome 22q11.2 duplication syndrome | Enrichment | TBX1 | 1.72 |
| 151 | Pseudohypoaldosteronism, type i, autosomal dominant | Enrichment | CUL3 | 1.72 |
| 152 | Lymphedema-distichiasis syndrome | Enrichment | FOXC2 | 1.72 |
| 153 | Aural atresia, congenital | Enrichment | FGFR2 | 1.72 |
| 154 | Cardiomyopathy, familial hypertrophic, 11 | Enrichment | ACTC1 | 1.72 |
| 155 | Smooth muscle dysfunction syndrome | Enrichment | ACTA2 | 1.72 |
| 156 | Encephalocraniocutaneous lipomatosis | Enrichment | FGFR1 | 1.72 |
| 157 | Solitary median maxillary central incisor | Enrichment | SHH | 1.72 |
| 158 | Schwannomatosis 2 | Enrichment | LZTR1 | 1.72 |
| 159 | Aortic aneurysm, familial thoracic 6 | Enrichment | ACTA2 | 1.72 |
| 160 | Neurodevelopmental disorder with spasticity, hypomyelinating leukodystrophy, and brain abnormalities | Enrichment | PI4KA | 1.72 |
| 161 | Moyamoya disease 5 | Enrichment | ACTA2 | 1.72 |
| 162 | Lymphoma, hodgkin, classic | Enrichment | TP53 | 1.72 |
| 163 | Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome | Enrichment | SNAP29 | 1.72 |
| 164 | Epilepsy, familial focal, with variable foci 3 | Enrichment | NPRL3 | 1.72 |
| 165 | Atrial septal defect 5 | Enrichment | ACTC1 | 1.72 |
| 166 | Antley-bixler syndrome without genital anomalies or disordered steroidogenesis | Enrichment | FGFR2 | 1.72 |
| 167 | Anterior segment dysgenesis 3 | Enrichment | FOXC1 | 1.72 |
| 168 | Tessadori-bicknell-van haaften neurodevelopmental syndrome 1 | Enrichment | H4C1 | 1.72 |
| 169 | Tessadori-bicknell-van haaften neurodevelopmental syndrome 2 | Enrichment | H4C1 | 1.72 |
| 170 | Neurodevelopmental disorder with dysmorphic facies and variable seizures | Enrichment | EMC10 | 1.72 |
| 171 | Intravascular large b-cell lymphoma | Enrichment | BCL2 | 1.72 |
| 172 | Split hand-foot malformation | Enrichment | FGFR2 | 1.72 |
| 173 | Rosette-forming glioneuronal tumor | Enrichment | FGFR1 | 1.72 |
| 174 | Pineoblastoma | Enrichment | DROSHA | 1.72 |
| 175 | Congenital fibrosarcoma | Enrichment | TP53 | 1.72 |
| 176 | Li-fraumeni syndrome 1 | Enrichment | TP53 | 1.72 |
| 177 | Sarcoma | Enrichment | TP53 | 1.72 |
| 178 | Noonan syndrome 10 | Enrichment | LZTR1 | 1.72 |
| 179 | Cervix carcinoma | Enrichment | TP53 | 1.72 |
| 180 | Immune system disease | Enrichment | CDC42 | 1.72 |
| 181 | Hodgkin's lymphoma | Enrichment | TP53 | 1.72 |
| 182 | Familial isolated congenital asplenia | Enrichment | NKX2-5 | 1.72 |
| 183 | Interfrontal craniofaciosynostosis | Enrichment | FGFR1 | 1.72 |
| 184 | Combined immunodeficiency-multiple intestinal atresia | Enrichment | PI4KA | 1.72 |
| 185 | Autosomal dominant nonsyndromic deafness | Enrichment | FGFR2 | 1.72 |
| 186 | Arthritis | Enrichment | RELN | 1.72 |
| 187 | Deletion 5q35 | Enrichment | NKX2-5 | 1.72 |
| 188 | Primary mediastinal large b-cell lymphoma | Enrichment | XPO1 | 1.72 |
| 189 | Isolated radial hemimelia | Enrichment | SHH | 1.72 |
| 190 | Pleomorphic rhabdomyosarcoma | Enrichment | TP53 | 1.72 |
| 191 | Kallmann syndrome | Enrichment | FGF8, FGFR1 | 1.69 |
| 192 | Cardiomyopathy, familial hypertrophic, 1 | Enrichment | LZTR1, RAF1 | 1.65 |
| 193 | Familial atrial fibrillation | Enrichment | NKX2-5, PITX2 | 1.65 |
| 194 | Tetralogy of fallot | Enrichment | NKX2-5, TBX1 | 1.59 |
| 195 | Crouzon syndrome | Enrichment | FGFR2 | 1.54 |
| 196 | Hypogonadotropic hypogonadism 2 with or without anosmia | Enrichment | FGFR1 | 1.54 |
| 197 | Pseudohypoaldosteronism, type iia | Enrichment | CUL3 | 1.54 |
| 198 | Syndactyly, type iv | Enrichment | SHH | 1.54 |
| 199 | Periventricular nodular heterotopia 1 | Enrichment | VWF | 1.54 |
| 200 | Ifap syndrome 1, with or without bresheck syndrome | Enrichment | SREBF1 | 1.54 |
| 201 | Nuchal bleb, familial | Enrichment | LZTR1 | 1.54 |
| 202 | Osteogenic sarcoma | Enrichment | TP53 | 1.54 |
| 203 | Nasopharyngeal carcinoma | Enrichment | TP53 | 1.54 |
| 204 | Leukodystrophy, hypomyelinating, 2 | Enrichment | SNAP29 | 1.54 |
| 205 | Chromosome 8p11 myeloproliferative syndrome | Enrichment | FGFR1 | 1.54 |
| 206 | Epilepsy, familial temporal lobe, 7 | Enrichment | RELN | 1.54 |
| 207 | Epilepsy, familial focal, with variable foci 2 | Enrichment | NPRL2 | 1.54 |
| 208 | Neonatal nephrocutaneous inflammatory syndrome | Enrichment | EGFR | 1.54 |
| 209 | Tessadori-bicknell-van haaften neurodevelopmental syndrome 4 | Enrichment | H4C1 | 1.54 |
| 210 | Tessadori-bicknell-van haaften neurodevelopmental syndrome 3 | Enrichment | H4C1 | 1.54 |
| 211 | Gyrate atrophy of choroid and retina | Enrichment | OAT | 1.54 |
| 212 | High-grade b-cell lymphoma double-hit/triple-hit | Enrichment | BCL2 | 1.54 |
| 213 | Polycystic kidney disease 4 | Enrichment | SHOC2 | 1.54 |
| 214 | Atypical teratoid rhabdoid tumor | Enrichment | TP53 | 1.54 |
| 215 | Anaplastic astrocytoma | Enrichment | TP53 | 1.54 |
| 216 | Hypoplastic or aplastic tibia with polydactyly | Enrichment | SHH | 1.54 |
| 217 | Kyphosis | Enrichment | RELN | 1.54 |
| 218 | Squamous cell carcinoma | Enrichment | TP53 | 1.54 |
| 219 | Adenocarcinoma | Enrichment | TP53 | 1.54 |
| 220 | Bone osteosarcoma | Enrichment | TP53 | 1.54 |
| 221 | Schwannomatosis | Enrichment | LZTR1 | 1.54 |
| 222 | Neonatal inflammatory skin and bowel disease | Enrichment | EGFR | 1.54 |
| 223 | Hereditary episodic ataxia | Enrichment | TANGO2 | 1.54 |
| 224 | Bladder cancer | Enrichment | EGFR, TP53 | 1.50 |
| 225 | Polydactyly, preaxial ii | Enrichment | SHH | 1.42 |
| 226 | Small cell cancer of the lung | Enrichment | TP53 | 1.42 |
| 227 | Emery-dreifuss muscular dystrophy 1, x-linked | Enrichment | LZTR1 | 1.42 |
| 228 | Schizencephaly | Enrichment | SHH | 1.42 |
| 229 | Thyroid cancer, nonmedullary, 1 | Enrichment | TP53 | 1.42 |
| 230 | Autoimmune lymphoproliferative syndrome | Enrichment | ACTA2 | 1.42 |
| 231 | Chromosome 22q11.2 deletion syndrome, distal | Enrichment | CRKL | 1.42 |
| 232 | Saethre-chotzen syndrome | Enrichment | FGFR2 | 1.42 |
| 233 | Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities | Enrichment | POLR2A | 1.42 |
| 234 | Emery-dreifuss muscular dystrophy | Enrichment | LZTR1 | 1.42 |
| 235 | Autosomal dominant nocturnal frontal lobe epilepsy | Enrichment | DEPDC5 | 1.42 |
| 236 | Lung sarcomatoid carcinoma | Enrichment | TP53 | 1.42 |
| 237 | Embryonal rhabdomyosarcoma | Enrichment | TP53 | 1.42 |
| 238 | Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia | Enrichment | CDC42 | 1.42 |
| 239 | Noonan syndrome with multiple lentigines | Enrichment | RAF1 | 1.42 |
| 240 | Newborn respiratory distress syndrome | Enrichment | NPRL2 | 1.42 |
| 241 | Episodic ataxia | Enrichment | TANGO2 | 1.42 |
| 242 | Hereditary progressive cardiac conduction defect | Enrichment | NKX2-5 | 1.42 |
| 243 | Full schwannomatosis | Enrichment | LZTR1 | 1.42 |
| 244 | Complex hereditary spastic paraplegia | Enrichment | PRKN | 1.42 |
| 245 | Glioma | Enrichment | FGFR2 | 1.42 |
| 246 | Familial hypertrophic cardiomyopathy | Enrichment | ACTC1, RAF1 | 1.40 |
| 247 | Dilated cardiomyopathy | Enrichment | ACTC1, NKX2-5, RAF1 | 1.37 |
| 248 | Hemifacial hyperplasia | Enrichment | FGFR2 | 1.32 |
| 249 | Lymphoma, mucosa-associated lymphoid type | Enrichment | MALT1 | 1.32 |
| 250 | Kbg syndrome | Enrichment | TBX1 | 1.32 |
| 251 | Polycystic kidney disease 3 with or without polycystic liver disease | Enrichment | SHOC2 | 1.32 |
| 252 | Parkinson disease 2, autosomal recessive juvenile | Enrichment | PRKN | 1.32 |
| 253 | Lissencephaly 2 | Enrichment | RELN | 1.32 |
| 254 | Follicular lymphoma | Enrichment | BCL2 | 1.32 |
| 255 | Lymphoma | Enrichment | TP53 | 1.32 |
| 256 | Juvenile glaucoma | Enrichment | FOXC1 | 1.32 |
| 257 | Parkin type of early-onset parkinson disease | Enrichment | PRKN | 1.32 |
| 258 | Acute megakaryocytic leukemia | Enrichment | TP53 | 1.32 |
| 259 | Aniridia | Enrichment | FOXC1 | 1.32 |
| 260 | Familial glucocorticoid deficiency | Enrichment | TXNRD2 | 1.32 |
| 261 | Primary hypereosinophilic syndrome | Enrichment | FGFR1 | 1.32 |
| 262 | Li-fraumeni syndrome | Enrichment | TP53 | 1.25 |
| 263 | Dystonia 11, myoclonic | Enrichment | DRD2 | 1.25 |
| 264 | Cowden syndrome 1 | Enrichment | EGFR | 1.25 |
| 265 | Hyperinsulinemic hypoglycemia, familial, 1 | Enrichment | GLUD1 | 1.25 |
| 266 | Split-hand/foot malformation 1 | Enrichment | FGFR2 | 1.25 |
| 267 | Moyamoya disease 1 | Enrichment | ACTA2 | 1.25 |
| 268 | Pain disorder | Enrichment | OAT | 1.25 |
| 269 | Adrenocortical carcinoma | Enrichment | TP53 | 1.25 |
| 270 | Double outlet right ventricle | Enrichment | NKX2-5 | 1.25 |
| 271 | Breast adenocarcinoma | Enrichment | TP53 | 1.25 |
| 272 | Lung squamous cell carcinoma | Enrichment | EGFR | 1.25 |
| 273 | Waardenburg syndrome | Enrichment | PAX3 | 1.25 |
| 274 | Nonsyndromic genetic hyperinsulinism | Enrichment | GLUD1 | 1.25 |
| 275 | Benign epilepsy with centrotemporal spikes | Enrichment | DEPDC5, RELN | 1.23 |
| 276 | Centralopathic epilepsy | Enrichment | DEPDC5, RELN | 1.19 |
| 277 | Gastric cancer | Enrichment | FGFR2, TP53 | 1.19 |
| 278 | Esophageal cancer | Enrichment | TP53 | 1.18 |
| 279 | Waardenburg syndrome, type 1 | Enrichment | PAX3 | 1.18 |
| 280 | Hypothyroidism, congenital, nongoitrous, 2 | Enrichment | NKX2-5 | 1.18 |
| 281 | Noonan syndrome 3 | Enrichment | RAF1 | 1.18 |
| 282 | Essential thrombocythemia | Enrichment | TP53 | 1.18 |
| 283 | Gallbladder cancer | Enrichment | TP53 | 1.18 |
| 284 | Autosomal dominant sleep-related hypermotor epilepsy | Enrichment | DEPDC5 | 1.18 |
| 285 | B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) | Enrichment | TP53 | 1.18 |
| 286 | Ovarian cancer | Enrichment | EGFR, PRKN, TP53 | 1.13 |
| 287 | Melanocytic nevus syndrome, congenital | Enrichment | RAF1 | 1.13 |
| 288 | Polycystic kidney disease 4 with or without polycystic liver disease | Enrichment | SHOC2 | 1.13 |
| 289 | Lymphoma, non-hodgkin, familial | Enrichment | TP53 | 1.13 |
| 290 | Hypoplastic left heart syndrome | Enrichment | NKX2-5 | 1.13 |
| 291 | Combined pituitary hormone deficiency | Enrichment | FOXA2 | 1.13 |
| 292 | Orofacial cleft 1 | Enrichment | FGF10 | 1.08 |
| 293 | Adult hepatocellular carcinoma | Enrichment | TP53 | 1.08 |
| 294 | Bilateral perisylvian polymicrogyria | Enrichment | PI4KA | 1.08 |
| 295 | Hypogonadotropic hypogonadism | Enrichment | FGFR1 | 1.08 |
| 296 | Primary hyperaldosteronism | Enrichment | TP53 | 1.08 |
| 297 | Leukemia, chronic lymphocytic | Enrichment | TP53 | 1.03 |
| 298 | Familial colorectal cancer | Enrichment | TP53 | 1.03 |
| 299 | Hereditary breast ovarian cancer syndrome | Enrichment | DROSHA, TP53 | 1.01 |
| 300 | Pectus excavatum | Enrichment | SHOC2 | 0.99 |
| 301 | Meningioma, familial | Enrichment | LZTR1 | 0.99 |
| 302 | Myelodysplastic syndrome | Enrichment | TP53 | 0.99 |
| 303 | Combined immunodeficiency | Enrichment | MALT1 | 0.99 |
| 304 | Atrial heart septal defect | Enrichment | NKX2-5 | 0.99 |
| 305 | Lung non-small cell carcinoma | Enrichment | EGFR | 0.99 |
| 306 | Combined t cell and b cell immunodeficiency | Enrichment | MALT1 | 0.99 |
| 307 | Interatrial communication | Enrichment | NKX2-5 | 0.99 |
| 308 | Combined t and b cell immunodeficiency | Enrichment | MALT1 | 0.99 |
| 309 | Presynaptic congenital myasthenic syndromes | Enrichment | SLC25A1 | 0.99 |
| 310 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | Enrichment | FGF8, LZTR1 | 0.99 |
| 311 | Early-onset parkinson's disease | Enrichment | PRKN | 0.96 |
| 312 | Aortic valve disease 1 | Enrichment | NKX2-5 | 0.93 |
| 313 | Nk-cell enteropathy | Enrichment | CUL3 | 0.93 |
| 314 | Hypogonadotropic hypogonadism 7 with or without anosmia | Enrichment | FGFR1 | 0.90 |
| 315 | Heart disease | Enrichment | NKX2-5 | 0.90 |
| 316 | Inherited cancer-predisposing syndrome | Enrichment | EGFR, LZTR1, TP53 | 0.87 |
| 317 | Hydrocephalus | Enrichment | FGFR2 | 0.87 |
| 318 | Rhabdomyosarcoma | Enrichment | TP53 | 0.84 |
| 319 | Dandy-walker syndrome | Enrichment | PPP1CB | 0.82 |
| 320 | Sudden infant death syndrome | Enrichment | DEPDC5 | 0.82 |
| 321 | Autism | Enrichment | PRKN, SHH | 0.81 |
| 322 | Arteriovenous malformations of the brain | Enrichment | EGFR | 0.77 |
| 323 | Diffuse large b-cell lymphoma | Enrichment | TP53 | 0.77 |
| 324 | Parkinson's disease | Enrichment | PRKN | 0.77 |
| 325 | Macs syndrome | Enrichment | SHH | 0.75 |
| 326 | Craniosynostosis | Enrichment | FGFR2 | 0.75 |
| 327 | Cardiomyopathy, dilated, 1a | Enrichment | HAND2 | 0.73 |
| 328 | Endometrial cancer | Enrichment | FGFR2 | 0.73 |
| 329 | Lissencephaly | Enrichment | RELN | 0.73 |
| 330 | Hepatoblastoma | Enrichment | TP53 | 0.73 |
| 331 | Hepatocellular carcinoma | Enrichment | TP53 | 0.72 |
| 332 | Tooth agenesis | Enrichment | FGFR1 | 0.72 |
| 333 | Diamond-blackfan anemia 1 | Enrichment | TP53 | 0.70 |
| 334 | Colorectal cancer | Enrichment | FGFR2, TP53 | 0.69 |
| 335 | Parkinson disease, late-onset | Enrichment | PRKN | 0.68 |
| 336 | Scoliosis | Enrichment | RELN | 0.68 |
| 337 | Pancreatic cancer | Enrichment | TP53 | 0.67 |
| 338 | Hydrops fetalis, nonimmune | Enrichment | FOXC2 | 0.65 |
| 339 | Hirschsprung disease 1 | Enrichment | SREBF1 | 0.61 |
| 340 | Prostate cancer | Enrichment | TP53 | 0.61 |
| 341 | Non-immune hydrops fetalis | Enrichment | FOXC2 | 0.58 |
| 342 | Connective tissue disease | Enrichment | ACTA2 | 0.57 |
| 343 | Severe combined immunodeficiency | Enrichment | MALT1 | 0.56 |
| 344 | Cakut | Enrichment | FOXC1 | 0.55 |
| 345 | Autism spectrum disorder | Enrichment | CUL3, PRKN | 0.55 |
| 346 | Diamond-blackfan anemia | Enrichment | TP53 | 0.53 |
| 347 | Leukemia, acute myeloid | Enrichment | TP53 | 0.49 |
| 348 | Epilepsy | Enrichment | DEPDC5 | 0.49 |
| 349 | Type 2 diabetes mellitus | Enrichment | SLC2A4 | 0.47 |
| 350 | Distal arthrogryposis | Enrichment | ACTC1 | 0.47 |
| 351 | Bardet-biedl syndrome | Enrichment | COMT | 0.47 |
| 352 | Complex neurodevelopmental disorder | Enrichment | CUL3, EMC10 | 0.47 |
| 353 | Hypertrophic cardiomyopathy | Enrichment | ACTC1 | 0.47 |
| 354 | Optic atrophy plus syndrome | Enrichment | OAT | 0.46 |
| 355 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | ACTA2 | 0.46 |
| 356 | Hereditary breast carcinoma | Enrichment | TP53 | 0.46 |
| 357 | Autosomal dominant non-syndromic intellectual disability | Enrichment | CDH15 | 0.41 |
| 358 | Hypertelorism | Enrichment | FGFR2 | 0.40 |
| 359 | Myeloma, multiple | Enrichment | TP53 | 0.38 |
| 360 | Breast cancer | Enrichment | TP53 | 0.29 |
| 361 | Rare genetic deafness | Enrichment | PAX3 | 0.27 |
| 362 | Hereditary retinal dystrophy | Enrichment | OAT | 0.03 |
| 363 | Fundus dystrophy | Enrichment | OAT | 0.03 |